thalidomide has been researched along with Tachycardia, Ventricular in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 65-year-old male with multiple myeloma received chemotherapy which included cyclophosphamide, thalidomide and dexamethasone." | 1.39 | Negative chronotropic effects and coronary ischaemic abnormalities following thalidomide therapy. ( Ali, A; Hothi, SS; Malik, N; Thompson, A, 2013) |
| "Sustained ventricular tachycardia possibly owing to thalidomide treatment." | 1.34 | Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia. ( Ballanti, S; Berchicci, L; Bolli, N; Capolsini, I; Giordano, G; Lotti, F; Mastrodicasa, E; Merigiola, C; Tabilio, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, A | 1 |
| Hothi, SS | 1 |
| Thompson, A | 1 |
| Malik, N | 1 |
| Ballanti, S | 1 |
| Mastrodicasa, E | 1 |
| Bolli, N | 1 |
| Lotti, F | 1 |
| Capolsini, I | 1 |
| Berchicci, L | 1 |
| Merigiola, C | 1 |
| Giordano, G | 1 |
| Tabilio, A | 1 |
2 other studies available for thalidomide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Negative chronotropic effects and coronary ischaemic abnormalities following thalidomide therapy.
Topics: Aged; Bradycardia; Coronary Vasospasm; Electrocardiography; Humans; Immunosuppressive Agents; Male; | 2013 |
Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.
Topics: Aged; Angiogenesis Inhibitors; Humans; Leukemia, Plasma Cell; Male; Tachycardia, Ventricular; Thalid | 2007 |